Published in J Am Chem Soc on March 31, 2007
Multimodality imaging probes: design and challenges. Chem Rev (2010) 2.61
Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem (2008) 1.37
Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater (2011) 1.33
In quest of a systematic framework for unifying and defining nanoscience. J Nanopart Res (2009) 1.25
Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med (2010) 1.21
Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence. ACS Nano (2013) 1.14
Multimodality Imaging of Integrin α(v)β(3) Expression. Theranostics (2011) 1.10
A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media Mol Imaging (2010) 1.07
Imaging and quantifying the morphology of an organic-inorganic nanoparticle at the sub-nanometre level. Nat Nanotechnol (2010) 1.04
Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents. Sci Rep (2013) 1.03
Multifunctional Magnetic Nanoparticles for Medical Imaging Applications. J Mater Chem (2009) 1.03
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol (2012) 1.03
Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics (2012) 0.96
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. MRS Bull (2009) 0.95
Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells. Cancer Nanotechnol (2014) 0.94
Gd₂O₃ nanoparticles in hematopoietic cells for MRI contrast enhancement. Int J Nanomedicine (2011) 0.91
Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging. Adv Mater (2014) 0.90
Multimodality and nanoparticles in medical imaging. Dalton Trans (2011) 0.89
Magnetic and optical properties of multifunctional core-shell radioluminescence nanoparticles. J Mater Chem (2012) 0.87
Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment. Cancer Nanotechnol (2014) 0.86
Analytical strategies for detecting nanoparticle-protein interactions. Analyst (2010) 0.85
Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents. J Am Chem Soc (2012) 0.85
Optical imaging in vivo with a focus on paediatric disease: technical progress, current preclinical and clinical applications and future perspectives. Pediatr Radiol (2011) 0.84
Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality. NMR Biomed (2013) 0.83
Potential dual imaging nanoparticle: Gd2O3 nanoparticle. Sci Rep (2015) 0.82
Collective activation of MRI agents via encapsulation and disease-triggered release. J Am Chem Soc (2013) 0.81
Dynamically Tuning the Up-conversion Luminescence of Er(3+)/Yb(3+) Co-doped Sodium Niobate Nano-crystals through Magnetic Field. Sci Rep (2016) 0.80
Extracellular biosynthesis of gadolinium oxide (Gd2O3) nanoparticles, their biodistribution and bioconjugation with the chemically modified anticancer drug taxol. Beilstein J Nanotechnol (2014) 0.80
Color Tunable Gd-Zn-Cu-In-S/ZnS Quantum Dots for Dual Modality Magnetic Resonance and Fluorescence Imaging. Nano Res (2014) 0.79
Nanotechnology applications for glioblastoma. Neurosurg Clin N Am (2012) 0.78
Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells. J Nanobiotechnology (2016) 0.77
Phospholipid micelle encapsulated gadolinium oxide nanoparticles for imaging and gene delivery. RSC Adv (2013) 0.77
A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study. J Nanobiotechnology (2014) 0.77
Functional nanoparticles for magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.77
Mixed lanthanide oxide nanoparticles as dual imaging agent in biomedicine. Sci Rep (2013) 0.77
Cancer optical imaging using fluorescent nanoparticles. Nanomedicine (Lond) (2011) 0.76
Tracking Transplanted Stem Cells Using Magnetic Resonance Imaging and the Nanoparticle Labeling Method in Urology. Biomed Res Int (2015) 0.76
Gold-silica quantum rattles for multimodal imaging and therapy. Proc Natl Acad Sci U S A (2015) 0.76
Size-dependent MRI relaxivity and dual imaging with Eu0.2Gd0.8PO4·H2O nanoparticles. Langmuir (2014) 0.75
Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitro. PLoS One (2014) 0.75
The High Radiosensitizing Efficiency of a Trace of Gadolinium-Based Nanoparticles in Tumors. Sci Rep (2016) 0.75
Poly(acrylic acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites as Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging. ACS Appl Mater Interfaces (2015) 0.75
Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles. Cancer Nanotechnol (2016) 0.75
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents. Proc Natl Acad Sci U S A (2017) 0.75
Chemically engineered persistent luminescence nanoprobes for bioimaging. Theranostics (2016) 0.75
The Arabidopsis Information Resource (TAIR): gene structure and function annotation. Nucleic Acids Res (2007) 14.24
The Arabidopsis Information Resource (TAIR): improved gene annotation and new tools. Nucleic Acids Res (2011) 8.18
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev (2010) 2.53
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
Toxicity of nanomaterials. Chem Soc Rev (2011) 2.07
Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging (2006) 1.97
Heterocyst differentiation and pattern formation in cyanobacteria: a chorus of signals. Mol Microbiol (2006) 1.88
Creation of a genome-wide metabolic pathway database for Populus trichocarpa using a new approach for reconstruction and curation of metabolic pathways for plants. Plant Physiol (2010) 1.77
Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc (2008) 1.77
Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging (2009) 1.66
The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer (2007) 1.63
Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev (2010) 1.63
The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells. J Proteome Res (2009) 1.58
Effects of prone position and positive end-expiratory pressure on lung perfusion and ventilation. Crit Care Med (2008) 1.50
MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci (2011) 1.47
The multiple roles of amphiregulin in human cancer. Biochim Biophys Acta (2011) 1.39
Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med (2002) 1.36
Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl (2011) 1.36
Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. J Am Chem Soc (2004) 1.32
A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chemistry (2013) 1.32
Cardiac and respiratory double self-gated cine MRI in the mouse at 7 T. Magn Reson Med (2006) 1.29
Graphene: promises, facts, opportunities, and challenges in nanomedicine. Chem Rev (2013) 1.28
Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res (2009) 1.25
p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene (2003) 1.20
In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography. J Biomed Opt (2008) 1.19
Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positive-contrast MR imaging. Radiology (2011) 1.19
Effect of nanoparticles on the cell life cycle. Chem Rev (2011) 1.19
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles. ACS Nano (2011) 1.18
Alveolar recruitment assessed by positron emission tomography during experimental acute lung injury. Intensive Care Med (2006) 1.18
In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer (2007) 1.17
Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovasc Res (2008) 1.17
ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion. Cancer Res (2012) 1.16
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol (2011) 1.16
Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. J Biomed Opt (2009) 1.15
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv Drug Deliv Rev (2011) 1.15
Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology (2004) 1.14
Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines. J Biol Chem (2002) 1.13
Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4. Mol Imaging (2006) 1.12
MRI detection of early endothelial activation in brain inflammation. Magn Reson Med (2004) 1.11
Engineered nanoparticles for biomolecular imaging. Nanoscale (2011) 1.11
Turbulentlike fluctuations in quasistatic flow of granular media. Phys Rev Lett (2002) 1.11
The receiver domain of FrzE, a CheA-CheY fusion protein, regulates the CheA histidine kinase activity and downstream signalling to the A- and S-motility systems of Myxococcus xanthus. Mol Microbiol (2008) 1.10
Cardiac and respiratory self-gated cine MRI in the mouse: comparison between radial and rectilinear techniques at 7T. Magn Reson Med (2007) 1.10
Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Mol Pharm (2009) 1.09
Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med (2013) 1.09
Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. Mol Ther (2009) 1.09
Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small (2009) 1.08
3D static elastography at the micrometer scale using Full Field OCT. Biomed Opt Express (2013) 1.08
Spin transition molecular materials: intelligent contrast agents for magnetic resonance imaging. J Am Chem Soc (2003) 1.08
Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano (2011) 1.07
An increase in the level of 2-oxoglutarate promotes heterocyst development in the cyanobacterium Anabaena sp. strain PCC 7120. Microbiology (2003) 1.07
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res (2009) 1.06
Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging. Nanomedicine (Lond) (2011) 1.04
Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. Contrast Media Mol Imaging (2013) 1.04
Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials (2012) 1.04
CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling. J Cell Biol (2013) 1.03
Serial in vivo spectroscopic nuclear magnetic resonance imaging of lactate and extracellular pH in rat gliomas shows redistribution of protons away from sites of glycolysis. Cancer Res (2007) 1.03
Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots. Langmuir (2009) 1.01
Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma. J Pathol (2011) 1.01
Collaborative patch-based super-resolution for diffusion-weighted images. Neuroimage (2013) 1.00
Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. Chem Rev (2012) 1.00
Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale (2013) 1.00
Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm (2010) 1.00
A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen (2006) 0.99
Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. Contrast Media Mol Imaging (2008) 0.99
Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands. Org Biomol Chem (2006) 0.99
Magnetic iron oxide nanoparticles for biomedical applications. Future Med Chem (2010) 0.99
MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice. NMR Biomed (2007) 0.99
Cell "vision": complementary factor of protein corona in nanotoxicology. Nanoscale (2012) 0.99